Cargando…
Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection
Signal transducers and activators of transcription (STAT) 1 is critical for cellular responses to type I interferons (IFN-Is), with the capacity to determine the outcome of viral infection. We previously showed that while wildtype (WT) mice develop mild disease and survive infection with lymphocytic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192509/ https://www.ncbi.nlm.nih.gov/pubmed/32310998 http://dx.doi.org/10.1371/journal.ppat.1008525 |
_version_ | 1783528025077317632 |
---|---|
author | Jung, So Ri Ashhurst, Thomas M. West, Phillip K. Viengkhou, Barney King, Nicholas J. C. Campbell, Iain L. Hofer, Markus J. |
author_facet | Jung, So Ri Ashhurst, Thomas M. West, Phillip K. Viengkhou, Barney King, Nicholas J. C. Campbell, Iain L. Hofer, Markus J. |
author_sort | Jung, So Ri |
collection | PubMed |
description | Signal transducers and activators of transcription (STAT) 1 is critical for cellular responses to type I interferons (IFN-Is), with the capacity to determine the outcome of viral infection. We previously showed that while wildtype (WT) mice develop mild disease and survive infection with lymphocytic choriomeningitis virus (LCMV), LCMV infection of STAT1-deficient mice results in a lethal wasting disease that is dependent on IFN-I and CD4(+) cells. IFN-Is are considered to act as a bridge between innate and adaptive immunity. Here, we determined the relative contribution of STAT1 on innate and adaptive immunity during LCMV infection. We show that STAT1 deficiency results in a biphasic disease following LCMV infection. The initial, innate immunity-driven phase of disease was characterized by rapid weight loss, thrombocytopenia, systemic cytokine and chemokine responses and leukocyte infiltration of infected organs. In the absence of an adaptive immune response, this first phase of disease largely resolved resulting in survival of the infected host. However, in the presence of adaptive immunity, the disease progressed into a second phase with continued cytokine and chemokine production, persistent leukocyte extravasation into infected tissues and ultimately, host death. Overall, our findings demonstrate the key contribution of STAT1 in modulating innate and adaptive immunity during type I interferon-mediated lethal virus infection. |
format | Online Article Text |
id | pubmed-7192509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-71925092020-05-11 Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection Jung, So Ri Ashhurst, Thomas M. West, Phillip K. Viengkhou, Barney King, Nicholas J. C. Campbell, Iain L. Hofer, Markus J. PLoS Pathog Research Article Signal transducers and activators of transcription (STAT) 1 is critical for cellular responses to type I interferons (IFN-Is), with the capacity to determine the outcome of viral infection. We previously showed that while wildtype (WT) mice develop mild disease and survive infection with lymphocytic choriomeningitis virus (LCMV), LCMV infection of STAT1-deficient mice results in a lethal wasting disease that is dependent on IFN-I and CD4(+) cells. IFN-Is are considered to act as a bridge between innate and adaptive immunity. Here, we determined the relative contribution of STAT1 on innate and adaptive immunity during LCMV infection. We show that STAT1 deficiency results in a biphasic disease following LCMV infection. The initial, innate immunity-driven phase of disease was characterized by rapid weight loss, thrombocytopenia, systemic cytokine and chemokine responses and leukocyte infiltration of infected organs. In the absence of an adaptive immune response, this first phase of disease largely resolved resulting in survival of the infected host. However, in the presence of adaptive immunity, the disease progressed into a second phase with continued cytokine and chemokine production, persistent leukocyte extravasation into infected tissues and ultimately, host death. Overall, our findings demonstrate the key contribution of STAT1 in modulating innate and adaptive immunity during type I interferon-mediated lethal virus infection. Public Library of Science 2020-04-20 /pmc/articles/PMC7192509/ /pubmed/32310998 http://dx.doi.org/10.1371/journal.ppat.1008525 Text en © 2020 Jung et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Jung, So Ri Ashhurst, Thomas M. West, Phillip K. Viengkhou, Barney King, Nicholas J. C. Campbell, Iain L. Hofer, Markus J. Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection |
title | Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection |
title_full | Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection |
title_fullStr | Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection |
title_full_unstemmed | Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection |
title_short | Contribution of STAT1 to innate and adaptive immunity during type I interferon-mediated lethal virus infection |
title_sort | contribution of stat1 to innate and adaptive immunity during type i interferon-mediated lethal virus infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192509/ https://www.ncbi.nlm.nih.gov/pubmed/32310998 http://dx.doi.org/10.1371/journal.ppat.1008525 |
work_keys_str_mv | AT jungsori contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection AT ashhurstthomasm contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection AT westphillipk contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection AT viengkhoubarney contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection AT kingnicholasjc contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection AT campbelliainl contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection AT hofermarkusj contributionofstat1toinnateandadaptiveimmunityduringtypeiinterferonmediatedlethalvirusinfection |